跳至主要内容
临床试验/NL-OMON31583
NL-OMON31583已完成4 期

A pilot study on the effect of apomorphine on visual perception in patients with Parkinson's disease and visual hallucinations - Apomorphine and visual hallucinations in Parkinson's disease

niversitair Medisch Centrum Groningen0 个研究点目标入组 10 人开始时间: 待定最近更新:
适应症

试验速览

阶段
4 期
状态
已完成
入组人数
10

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
18 至 99(—)

入选标准

  • 1. Diagnosed Parkinson*s Disease according to the UK Brain Bank Criteria
  • 2. Al least weekly hallucinations during the past month
  • 3. MMSE >24
  • 4. FAB>=12
  • 5. Patient must be able to understand the procedure
  • 6. Medication must be stable for at least a month

排除标准

  • 1. Visual problems (cataract, macula degeneration, severe retinal patholgy, visus<.5)
  • 2. Patients with cerebral electrodes for deep brain stimulation
  • 3. Presence of other neurological or psychiatric affections
  • 4. Unstable internal disease
  • 5. Patients who already use apomorphine

研究者

相似试验